INS and cancer: This pathophysiological reaction increases plasma insulin levels, resulting in hyperinsulinemia, which is associated with an increased risk of initiation, progression and metastasis of several cancers; poor cancer outcomes; as well as the development of metabolic diseases, such as type 2 diabetes mellitus (T2DM), metabolic syndrome, etc. [5].